Actively Recruiting

Age: 18Years +
FEMALE
ID04595201

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

Led by Sequenom, Inc. · Updated on 2024-10-16

25000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Sequenom, Inc.

Lead Sponsor

I

Integrated Genetics

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to collect pregnancy outcome information from women who have undergone non-invasive pregnancy testing (NIPT) to check the genetic status of their fetus. The study evaluates the performance of routine improvements to the NIPT assay and seeks to identify factors linked to negative pregnancy outcomes. This observational study focuses on pregnant women aged 18 and older who received testing through Sequenom or Integrated Genetics. Participants in this study have already undergone NIPT as part of their routine care. Researchers will review the testing results and pregnancy outcomes without providing any additional treatments or interventions. The study uses data collected from the non-invasive testing device and gathers information about pregnancy progress and outcomes to analyze test effectiveness and related characteristics. During the study, researchers will collect and analyze data about pregnancy outcomes up to nine months after testing. No extra procedures or visits are required beyond standard care. The main goal is to assess how well the NIPT performs clinically and to understand factors that may influence pregnancy results. Participation involves sharing pregnancy outcome information for research purposes only.

CONDITIONS

Brief Title

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject was pregnant and received NIPT from Sequenom/Integrated Genetics
  • Subject was 18 years of age or older at the time of NIPT
  • Pregnancy outcome is available
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to delivery

Participants undergo non-invasive pregnancy testing (NIPT) as part of routine clinical care.

1 visit (in-person) for testing

Long-term Monitoring

Duration - Up to 9 months

Participants are followed to collect pregnancy outcome data for analysis.

Follow-up contacts aligned with pregnancy milestones

Trial Site Locations

Total: 1 location

1

Integrated Genetics

Westborough, Massachusetts, United States, 01581

Actively Recruiting

Loading map...

Research Team

K

Kimberly Fanelli, MS, CGC

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Development and Validation of a Prediction Model for Adverse...

Aplastic Anemia

Actively Recruiting

1 location

A Repository to Study Host-Microbiome Interactions in Health...

Healthy Controls

Actively Recruiting

1 location

A Prospective Validation of the Enlighten Device in Predicti...

Postpartum Depression (PPD)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here